
    
      Patients with know prostate cancer (PCa) under active surveillance (Gleason 6, PSA < 10
      ng/ml) and aged matched controls without evidence of PCa will have a PSA blood test prior to
      and following standardized digital rectal examination.

      The change of PSA will be evaluated.
    
  